CD44 and prostate cancer: Yu et al. [48] have identified high ALDH1 activity in LNCaP and PC-3 prostate cancer cells associated with CSC-like properties; in particular, ALDHhi/CD44+ cells possess a high clonogenic function and tumorigenic potential.